Article PDF
Rights and permissions
About this article
Cite this article
Gershon, D. Frustrated by regulatory delays at FDA, biotech companies warm to user fees. Nature 358, 616 (1992). https://doi.org/10.1038/358616a0
Issue Date:
DOI: https://doi.org/10.1038/358616a0